Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263055
Status:
COMPLETED
Last Update Posted:
2009-09-15
First Post:
2005-12-06
Brief Title:
MASCOT Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin5FU-LV
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin5FU-LV
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Safety tolerability of FOLFOX4 regimen in the adjuvant treatment of colon cancer in Asian patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None